Home -
COMPANY                
TEAM
CONTACTS
CUSTOMER REFERENCES 
PUBLICATIONS
PRESS
   
PRODUCTS

PARKINSONIAN SYNDROMES
OCULOMOTRICITY IN PARKINSONIAN SYNDROMES

PATIENTS WITH PARKINSONIAN SYNDROMES PRESENT SPECIFIC PATTERNS OF ABNORMAL EYE MOVEMENTS

Parkinsonian Syndromes
SND: Striatonigral Degeneration; CBD: Corticobasal Degeneration; PSP: Progressive Supranuclear Palsy, N: normal; Lat.: latency; Acc.: accuracy; Sacc.: saccade. Green: discriminating factors.

By taking these oculomotor symptoms patterns into account, the Mobile EBT® reliably and significantly improve early syndrome discrimination.
This in turn:
• Helps patients and caretakers cope with the disease
• Facilitates disease-management and monitoring
• Improves the quality of clinical trials data by helping determining homogeneous patients groups

OCULOMETRIC CLINICAL EXAMINATION CAN REVEAL TWO TYPES OF EYE-MOVEMENT DISORDERS:

Distinctive criteria (DC): disorders that are highly correlated to a specific disease
Confirmatory criteria (CC): disorders that are generic of neurological dysfunction

To give a sense of this distinction, criteria are listed below for the case of Progressive Supranuclear Palsy (PSP), the most frequent non-idiopathic parkinsonian syndrome :

DC: PSP-SPECIFIC OCULOMOTOR IMPAIRMENTS:

Slower vertical saccades (latency and speed)
Asymmetry in the speed of up/down vertical saccades
Presence of square waves during fixation and anti-saccades tasks
High rate of errors in anti-saccades tasks

CC: GENERIC IMPAIRMENTS FOUND IN PSP PATIENTS:

During horizontal visually guided saccades:
Irregular trace and instable inter-saccades
Hypometric saccades (gain << 0.92)
Longer latencies

PSP Trace
Abnormalities in PSP Patient eye movements


 
Communiqué de Presse ParkinsonCommuniqué de presse Parkinson 24.04.2013
Silver Economy
Inauguration

... April 24th 2013
e(ye)BRAIN participated in the launch of the Silver Economy by the french government.
e(ye)BRAIN was chosen by the organizers to present the company and its assets for the silver economy.
To view the presentations of that day, including the one of our CEO,
click here.
 

 
INOS 20104th SMDSJNLF 2013 21-24.05.2013
The ABN
Annual Meeting

... May 21th to 24th 2013
e(ye)BRAIN will attend the annual meeting of the association of british neurologists (TheABN 2013) in Glasgow (scotland) from may 21st to 24th 2013.
e(ye)BRAIN will present its new medical device EyeBrain T2.
For further information, click here.
  
Forum e(ye)BRAIN
 
Company - Philosophy - Description - History - Agenda - Scientific Council - Partners - Investors - Customer references - Team - The Board - Management - Serge Kinkingnehun - Mickael Maillard - Magali Seassau - Maryline Zany - Research & Developement - Julien Erny - Tasnim Hedoui - Xavier Pecheur - Science - Magali Seassau - Marketing & Communication - Pierre-Yves Joyeux - Business development - Armelle Roussac - Quality & Regulatory Aspects - Sabine Guehenneux - IT & NETWORKS - Frederic Fatou - Production & after sales service - Bastien Oliviero - Administration - Emilie Geoffroy - Maryline Zany - Collaborations - Publications - e(ye)BRAIN R&D - e(ye)BRAIN products - Referencing - Contacts - Commercial Service - Customer Service - Press - Press - In the news - Press Release - Newsletters - Overview - Eye Movement - Eye Brain Tracker - Products - Mobile EBT - Medical Device - Technical Specifications - Classic Neurology Application - Parkinsonian Syndromes - Multiple Sclerosis - Technical Specifications CNA - Reading Application - Reading - Dyslexia - Technical specifications RA - Installations - Pitie-Salpetriere Hospital, Paris - Description - Products - meyeparadigm - meyeanalysis - Download - Installations - Dr Carole Azuar - Dr Hernan Picard - Sophie Rivaud-Pechoux - Description - Products - Installations -